Yuxian Qian

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Jiangsu Cancer Hospital(Current)

Nanjing Medical University

Yuxian Qian is an author at Jiangsu Cancer Hospital specializing in epidermal growth factor receptor inhibition, immunohistochemical biomarkers, and cancer pharmacology.

ORCID

Publications per year

2021–2024

Publications

Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancer in vitro and in vivo

Tao Li, Yuxian Qian, Chenfei Zhang et al. · Translational Lung Cancer Research · 2021 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The circRNA cEMSY Induces Immunogenic Cell Death and Boosts Immunotherapy Efficacy in Lung Adenocarcinoma

Yijian Zhang, Xuming Song, Yipeng Feng et al. · Cancer Research · 2024 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

1–2 of 2